Eric Sousa
Pfizer (United States)(US)Nanomed (Brazil)(BR)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Advanced Proteomics Techniques and Applications, Glycosylation and Glycoproteins Research, T-cell and B-cell Immunology, Mass Spectrometry Techniques and Applications
Most-Cited Works
- → Mild Method for Succinimide Hydrolysis on ADCs: Impact on ADC Potency, Stability, Exposure, and Efficacy(2014)185 cited
- → Differential Proteomic Analysis of Bronchoalveolar Lavage Fluid in Asthmatics following Segmental Antigen Challenge(2005)172 cited
- → Acid-Labile Isotope-Coded Extractants: A Class of Reagents for Quantitative Mass Spectrometric Analysis of Complex Protein Mixtures(2002)87 cited
- → Integrating titania enrichment, iTRAQ labeling, and Orbitrap CID‐HCD for global identification and quantitative analysis of phosphopeptides(2010)36 cited
- → Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing(2018)30 cited
- → Proteomic Identification of Endothelial Proteins Isolated in Situ from Atherosclerotic Aorta via Systemic Perfusion(2007)29 cited
- → Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease(2020)28 cited
- → Pyroglutamate and O-Linked Glycan Determine Functional Production of Anti-IL17A and Anti-IL22 Peptide-Antibody Bispecific Genetic Fusions(2012)20 cited
- → Mechanistic understanding of the cysteine capping modifications of antibodies enables selective chemical engineering in live mammalian cells(2017)19 cited
- → Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors(2021)15 cited